Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
基本信息
- 批准号:10400886
- 负责人:
- 金额:$ 31.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
The successful sequencing of the human genome and the evolution of human health services research in the
post-genomic era have offered unprecedented opportunities to transform patient care in digestive diseases.
Over the past decade, Weill Cornell Medicine (WCM) has made major investments in biomedical research, as
well as research training and infrastructure. This application from WCM requests support for the research
training of 4 clinical and non-clinical postdoctoral fellows in a new multidisciplinary research training program
(MRTP) in Gastroenterology and Hepatology, with WCM providing funding for an additional training slot. The
objective is to recruit outstanding candidates with solid foundations in basic science and train them to apply
their knowledge and skills towards addressing important clinically unmet needs in the prevention, diagnosis,
and treatment of patients with digestive diseases. MRTP trainees will receive program support for 2 years
during which they will follow a structured and rigorous postdoctoral training program. The MRTP will be a joint
effort of 28 eminent preceptors from WCM, Memorial Sloan Kettering Cancer Center (MSKCC) and the
Rockefeller University (RU), which constitute a dense network of collaborative researchers, who are
international leaders in fields directly relevant to gastroenterology and hepatology. These preceptors have
been organized into 3 themed, but interconnected units of research training: gastrointestinal malignancies, liver
diseases and regeneration, and mucosal immunology and inflammation. These training units will enable the
development of content-specific educational programming, as well as increase the efficiency administration
within the training program. Oversight will be provided by a Research Training Executive Committee consisting
of the Program Director and 2 Associate Program Directors, who will also serve as leaders of the training units,
as well as 3 additional members who will provide specific guidance on clinical/epidemiologic research, on
achieving and maintaining diversity within the training program, and on mentoring. We have also assembled an
outstanding roster of internal and external advisory board members with a mandate to evaluate the program
and provide specific recommendations to improve both its quality and efficiency. The MRTP's highly
personalized training program will include 1) individual development plans; 2) rigorous research training; 3)
hands-on experience in cutting-edge methodologies; and 4) an integrated curriculum. Trainees will further
benefit from the extensive institutional resources of WCM, MSKCC and RU. Based upon the levels of interest
in our fellowship programs, we anticipate a substantial pool of highly qualified clinical and non-clinical
candidates for the proposed MRTP, which will maintain a strong diversity focus. Through its rigorous,
structured and highly personalized curriculum, this new training program seeks to train future leaders in
digestive disease research who are prepared to translate their findings towards improving patient care.
项目总结
人类基因组测序的成功和人类健康服务研究的进展
后基因组时代为消化系统疾病的患者护理提供了前所未有的机会。
在过去的十年中,威尔·康奈尔医学公司(WCM)在生物医学研究方面进行了重大投资,如
以及研究、培训和基础设施。WCM的这一应用程序请求为研究提供支持
在新的多学科研究培训方案中培训4名临床和非临床博士后研究员
胃肠病和肝病学(MRTP),WCM为额外的培训时段提供资金。这个
目标是招募在基础科学方面有扎实基础的优秀应聘者,并培养他们应用
他们的知识和技能,以满足重要的临床未得到满足的需求,在预防,诊断,
以及消化系统疾病患者的治疗。MRTP学员将获得为期2年的计划支持
在此期间,他们将遵循系统和严格的博士后培训计划。MRTP将是一个联合
来自WCM、纪念斯隆·凯特琳癌症中心(MSKCC)和
洛克菲勒大学(RU),这构成了一个密集的合作研究人员网络,他们是
在与胃肠病和肝病直接相关的领域处于国际领先地位。这些戒律有
被组织成3个主题,但相互关联的研究培训单元:胃肠道恶性肿瘤,肝脏
疾病和再生,以及粘膜免疫学和炎症。这些培训单位将使
开发针对具体内容的教育规划,以及提高管理效率
在培训计划中。监督将由一个研究培训执行委员会提供,该委员会由
方案主任和2名协理方案主任,他们也将担任培训单位的负责人,
以及另外3名成员,他们将就临床/流行病学研究提供具体指导,
在培训计划和指导方面实现并保持多样性。我们还组装了一个
有权评估该方案的优秀内部和外部咨询委员会成员名单
并提出具体建议,以提高其质量和效率。MRTP的高度
个性化培训计划将包括1)个人发展计划;2)严格的研究培训;3)
在尖端方法方面的实践经验;以及4)综合课程。学员将进一步
受益于WCM、MSKCC和RU的广泛机构资源。基于兴趣的级别
在我们的奖学金计划中,我们预计会有大量高质量的临床和非临床人才。
拟议的MRTP的候选人,这将保持强烈的多样性重点。通过其严格的、
结构化和高度个性化的课程,这一新的培训计划旨在培训未来的领导者在
准备将他们的发现转化为改善患者护理的消化系统疾病研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
randy s longman其他文献
randy s longman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('randy s longman', 18)}}的其他基金
A randomized, placebo-controlled clinical trial examining the efficacy of Fecal Microbiota Transplantation (FMT) and subsequent dietary fiber in patients with moderate ulcerative colitis (MINDFUL)
一项随机、安慰剂对照临床试验,检验粪便微生物群移植 (FMT) 和随后的膳食纤维对中度溃疡性结肠炎 (MINDFUL) 患者的疗效
- 批准号:
10631895 - 财政年份:2021
- 资助金额:
$ 31.62万 - 项目类别:
A randomized, placebo-controlled clinical trial examining the efficacy of Fecal Microbiota Transplantation (FMT) and subsequent dietary fiber in patients with moderate ulcerative colitis (MINDFUL)
一项随机、安慰剂对照临床试验,检验粪便微生物群移植 (FMT) 和随后的膳食纤维对中度溃疡性结肠炎 (MINDFUL) 患者的疗效
- 批准号:
10183772 - 财政年份:2021
- 资助金额:
$ 31.62万 - 项目类别:
A randomized, placebo-controlled clinical trial examining the efficacy of Fecal Microbiota Transplantation (FMT) and subsequent dietary fiber in patients with moderate ulcerative colitis (MINDFUL)
一项随机、安慰剂对照临床试验,检验粪便微生物群移植 (FMT) 和随后的膳食纤维对中度溃疡性结肠炎 (MINDFUL) 患者的疗效
- 批准号:
10385825 - 财政年份:2021
- 资助金额:
$ 31.62万 - 项目类别:
TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis
TL1A 对结肠炎中第 3 组先天淋巴细胞的调节
- 批准号:
10357907 - 财政年份:2020
- 资助金额:
$ 31.62万 - 项目类别:
TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis
TL1A 对结肠炎中第 3 组先天淋巴细胞的调节
- 批准号:
9886697 - 财政年份:2020
- 资助金额:
$ 31.62万 - 项目类别:
TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis
TL1A 对结肠炎中第 3 组先天淋巴细胞的调节
- 批准号:
10589869 - 财政年份:2020
- 资助金额:
$ 31.62万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
10612780 - 财政年份:2019
- 资助金额:
$ 31.62万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
10632345 - 财政年份:2019
- 资助金额:
$ 31.62万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
10133062 - 财政年份:2019
- 资助金额:
$ 31.62万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
10621459 - 财政年份:2019
- 资助金额:
$ 31.62万 - 项目类别:
相似海外基金
Integrating Treatments for Alcohol Use Disorder into Hepatology Clinics
将酒精使用障碍的治疗纳入肝病诊所
- 批准号:
10785211 - 财政年份:2023
- 资助金额:
$ 31.62万 - 项目类别:
Testing an mHealth System for Integrating Alcohol Use Treatment with Hepatology Care for Patients with Alcohol-associated Liver Disease
测试将酒精使用治疗与肝病护理相结合的移动医疗系统,以治疗酒精相关性肝病患者
- 批准号:
10818885 - 财政年份:2023
- 资助金额:
$ 31.62万 - 项目类别:
Training Program in Investigative Gastroenterology and Hepatology
胃肠病学和肝病学研究培训计划
- 批准号:
10628499 - 财政年份:2023
- 资助金额:
$ 31.62万 - 项目类别:
HEP DART 2021: FRONTIERS IN DRUG DEVELOPMENT FOR HEPATOLOGY
HEP DART 2021:肝病药物开发前沿
- 批准号:
10391910 - 财政年份:2021
- 资助金额:
$ 31.62万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
9922266 - 财政年份:2019
- 资助金额:
$ 31.62万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
10612780 - 财政年份:2019
- 资助金额:
$ 31.62万 - 项目类别:
HEP DART 2019: Frontiers in Drug Development for Hepatology
HEP DART 2019:肝病药物开发前沿
- 批准号:
9914390 - 财政年份:2019
- 资助金额:
$ 31.62万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
10632345 - 财政年份:2019
- 资助金额:
$ 31.62万 - 项目类别: